(MENAFN– America News Hour)

In a recently published report, Proton Pump Inhibitors Market report for till 2030. The report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.

U S Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analysis and U.S. Census Bureau mention the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) average exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilst imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Proton Pump Inhibitors Market products.

Download Sample of This Strategic Report: 

Moreover, increasing expenditure on healthcare, backed by the need amongst individuals for quality healthcare services, is also anticipated to contribute to the market growth. According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018.

Proton pump inhibitors are a group of drugs whose main function is a pronounced and long-lasting reduction of gastric acid secretion in the linings of the stomach. They irreversibly block the enzyme process that actively transports gastric acid from parietal cells to the gastrointestinal lumen in the form of hydrogen-potassium adenosine triphosphate (proton pump). Proton pump inhibitors are used to relieve the symptoms of gastro-oesophageal reflux diseases (GERD), gastritis, peptic ulcers, Dyspepsia, Barrett’s oesophagus, Gastrinomas and other conditions that cause hypersecretion of gastric acid.Proton pump inhibitors are among the most widely used medications in the world, with the first one, omeprazole, being on the WHO Model List of Essential Medicines.

Market Dynamics
Increasing consumer acceptance of novel drug delivery systems, launch of new products, increasing shift from prescription drugs to over-the-counter products, and rising prevalence of peptic ulcer and other gastro-intestinal disorders are the key factors propelling the growth of the market.Conversely, the increasing use of generic drugs hampers the market growth. Consumers in isolated and rural regions tend to prefer the common antacids to deal with ulcer & other gastro-intestinal conditions.
Market Segmentation
The global proton pump inhibitors market is fragmented mainly on the basis of the drug type.
Drug Type
Omeprazole
Rabeprazole
Pantoprazole
Lansoprazole
Dexlansoprazole
Esomeprazole
The patent license of drug Esomeprazole expired in the year 2015, which is the major reason for the likely domination of Omeprazole & Lansoprazole in the market during the forecast period.
Geographical Analysis
North America had the dominant market share in 2015, which is mainly attributed to a consistent launch of new products and a rapidly increasing prevalence of gastrointestinal disorders in the region. However, the Asia Pacific market is anticipated to grow at a higher CAGR in the forecast period. The Asia Pacific region is flooded with numerous gastrointestinal drug products in addition to a large patient pool with gastro intestinal problems. This creates a need for curative drugs and is expected to drive the market growth remarkably.
Request For Full Report:
Key Players
Some of the prominent players dominating the proton pump Inhibitors market are AstraZeneca, Takeda Pharmaceuticals, Wyeth Pharmaceuticals, Eisai Pharmaceuticals India Pvt. Ltd., Teva Pharmaceuticals, Cadila Pharmaceuticals, Pfizer, Eli Lilly and Company, and Janssen Global Services, LLC.Many other companies in this field are adopting product enhancements and launches, acquisitions, and agreements as their key business strategies in order to top the global market.
About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Kenneth Research

Email :

Phone: +1 313 462 0609

Leonard Thomas

Leonard Thomas is an energetic and versatile freelance writer for 5 years, he pen down any type of articles and web content. he is a Cambridge University Business English Certificate (Europe Level) holder . he is analytical, enthusiastic and ingenious, with the essence to work variously, strives to emerge as a lucrative individual who has a grasp on market. Congenial Interpersonal skills and the competence to grab every single trivia with foolproof analysis is something he primarily posses .

MENAFN05012022004545010068ID1103490582

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.